Botulinum toxin has an increased effect when targeted toward the muscle’s endplate zone: A high-density surface EMG guided study

Bakheit, 2006, The possible adverse effects of intramuscular botulinum toxin injections and their management, Curr Drug Saf, 1, 271, 10.2174/157488606777934431 Borodic, 1991, Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy, Ophthal Plast Reconstr Surg, 7, 54, 10.1097/00002341-199103000-00007 Borodic, 1994, Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections, Mov Disord, 9, 31, 10.1002/mds.870090106 Borodic, 1990, Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread, Head Neck, 12, 392, 10.1002/hed.2880120504 Brans, 1995, Botulinum toxin in cervical dystonia: low dosage with electromyographic guidance, J Neurol, 242, 529, 10.1007/BF00867425 Breidenbach, 2005, New insights into clostridial neurotoxin–SNARE interactions, Trends Mol Med, 11, 377, 10.1016/j.molmed.2005.06.012 Castroflorio, 2005, Non-invasive assessment of motor unit anatomy in jaw-elevator muscles, J Oral Rehabil, 32, 708, 10.1111/j.1365-2842.2005.01490.x Childers, 2003, The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin, Phys Med Rehabil Clin N Am, 14, 781, 10.1016/S1047-9651(03)00047-0 Childers, 2004, Targeting the neuromuscular junction in skeletal muscles, Am J Phys Med Rehabil, 83, S38, 10.1097/01.PHM.0000141129.23219.42 Childers, 1998, Evaluating motor end-plate-targeted injections of botulinum toxin type A in a canine model, Muscle Nerve, 21, 653, 10.1002/(SICI)1097-4598(199805)21:5<653::AID-MUS15>3.0.CO;2-W Collins, 2006, Botulinum toxin injection for congenital muscular torticollis presenting in children and adults, Neurology, 67, 1083, 10.1212/01.wnl.0000237336.65596.21 Dressler, 2007, Pharmacology of therapeutic botulinum toxin preparations, Disabil Rehabil, 29, 1761, 10.1080/09638280701568296 Dressler, 2006, Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc, Eur J Neurol, 13, 11, 10.1111/j.1468-1331.2006.01439.x Eleopra, 1996, Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion, Neurology, 46, 1158, 10.1212/WNL.46.4.1158 Falla, 2002, Location of innervation zones of sternocleidomastoid and scalene muscles – a basis for clinical and research electromyography applications, Clin Neurophysiol, 113, 57, 10.1016/S1388-2457(01)00708-8 Farina, 2002, Surface EMG crosstalk between knee extensor muscles: experimental and model results, Muscle Nerve, 26, 681, 10.1002/mus.10256 Gracies, 2009, Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study, Arch Phys Med Rehabil, 90, 9, 10.1016/j.apmr.2008.04.030 Greene, 1994, Development of resistance to botulinum toxin type A in patients with torticollis, Mov Disord, 9, 213, 10.1002/mds.870090216 Happak, 1997, Human facial muscles: dimensions, motor endplate distribution, and presence of muscle fibers with multiple motor endplates, Anat Rec, 249, 276, 10.1002/(SICI)1097-0185(199710)249:2<276::AID-AR15>3.0.CO;2-L Jankovic, 1990, Botulinum toxin injections for cervical dystonia, Neurology, 40, 277, 10.1212/WNL.40.2.277 Jankovic, 2003, Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia, Neurology, 60, 1186, 10.1212/01.WNL.0000055087.96356.BB Lapatki, 2006, Topographical characteristics of motor units of the lower facial musculature revealed by means of high-density surface EMG, J Neurophysiol, 95, 342, 10.1152/jn.00265.2005 Lapatki, 2004, A thin, flexible multielectrode grid for high-density surface EMG, J Appl Physiol, 96, 327, 10.1152/japplphysiol.00521.2003 Ludlow, 1988, Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia, Neurology, 38, 1220, 10.1212/WNL.38.8.1220 Masuda, 1983, The propagation of motor unit action potential and the location of neuromuscular junction investigated by surface electrode arrays, Electroencephalogr Clin Neurophysiol, 55, 594, 10.1016/0013-4694(83)90171-2 Masuda, 1988, Topographical map of innervation zones within single motor units measured with a grid surface electrode, IEEE Trans Biomed Eng, 35, 623, 10.1109/10.4595 Naumann, 2008, Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, 70, 1707, 10.1212/01.wnl.0000311390.87642.d8 Sampaio, 2004, Clinical comparability of marketed formulations of botulinum toxin, Mov Disord, 19, S129, 10.1002/mds.20066 Shaari, 1993, Quantifying how location and dose of botulinum toxin injections affect muscle paralysis, Muscle Nerve, 16, 964, 10.1002/mus.880160913 Simpson, 2008, Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, 70, 1699, 10.1212/01.wnl.0000311389.26145.95 Simpson, 2008, Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, 70, 1691, 10.1212/01.wnl.0000311391.00944.c4 Sloop, 1996, Dose–response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A, Neurology, 46, 1382, 10.1212/WNL.46.5.1382 Stegeman, 2004, Multichannel surface EMG Truong, 2006, Botulinum toxin: clinical use, Parkinsonism Relat Disord, 12, 331, 10.1016/j.parkreldis.2006.06.002 van Dijk, 2009, Evidence of potential averaging over the finite surface of a bioelectric surface electrode, Ann Biomed Eng, 37, 1141, 10.1007/s10439-009-9680-7 Warfel, 1985